On 2 October, the Municipality of Cagliari hosted the presentation of the Sardinian HorizonCraft training pathway, a free programme addressed to young people under 30 and designed to strengthen their professional skills and prepare them for an increasingly international labour market.
The pathway combines 80 hours of training with the opportunity, for 15 selected participants, to undertake a three-month internship in Egypt. The training programme will focus on personal, professional, digital and entrepreneurial competences, including communication, teamwork, problem solving, leadership, personal branding, the Business Model Canvas, digital tools and applications of artificial intelligence.
The press conference brought together representatives of local institutions, the Interreg NEXT MED Programme, youth organisations and the business sector.
Contributions were provided by Marco Benucci, President of the Cagliari City Council; Carlo Serra, Councillor for Economic Development and Productive Sectors of the Municipality of Cagliari; Antonello Chessa, representing the Managing Authority of the Interreg NEXT MED Programme; Pierpaolo Spada, Secretary of Confartigianato Imprese Sud Sardegna; and Angelica Perra, HorizonCraft Project Manager.
Their contributions highlighted the connection at the heart of HorizonCraft: training young people while building stronger links with enterprises and creating opportunities for professional mobility across the Mediterranean.
But one of the most immediate perspectives came from a young person.Yara Ali, a young Egyptian volunteer currently working with TDM 2000 in Sardinia, spoke about what an experience in Egypt can offer a young Sardinian participant beyond the professional dimension. Living and working in another country means encountering a different culture, learning to relate to new people and environments, and discovering personal resources that often emerge only when leaving familiar surroundings.The learning activities are scheduled to start on October 15th in the city of Cagliari.
Next Med
